BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10447826)

  • 1. The effect of sex on antipyrine metabolism in cattle at different ages.
    Janus K; Antoszek J
    J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age on the pharmacokinetics of antipyrine in calves.
    Janus K; Suszycka J
    Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of short-term water deprivation on antipyrine disposition in calves.
    Janus K; Muszczynski Z; Suszycka J
    Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
    Jiang SX; Bayón JE; Ferre I; Mao XZ; González-Gallego J
    Vet Parasitol; 2000 Mar; 88(3-4):177-86. PubMed ID: 10714456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
    St Peter JV; Abul-Hajj Y; Awni WM
    Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species- and sex-related differences in the plasma clearance and metabolite formation of antipyrine. A comparative study in four animal species: cattle, goat, rat and rabbit.
    Witkamp RF; Lohuis JA; Nijmeijer SM; Kolker HJ; Noordhoek J; van Miert AS
    Xenobiotica; 1991 Nov; 21(11):1483-92. PubMed ID: 1763522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.
    Schellens JH; van der Wart JH; Danhof M; van der Velde EA; Breimer DD
    Br J Clin Pharmacol; 1988 Oct; 26(4):373-84. PubMed ID: 3190987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
    van Bezooijen CF; van Oorschot RM
    J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine pharmacokinetics and urinary excretion in female horses.
    Dyke TM; Sams RA; Hinchcliff KW
    Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
    Janus K; Muszczynski Z; Suszycka J
    J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.
    Yang BB; Hounslow NJ; Sedman AJ; Forgue ST
    J Clin Pharmacol; 1996 Apr; 36(4):356-60. PubMed ID: 8728350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of antipyrine and metabolites in plasma of a patient with mild renal failure.
    Lanchote VL; Ping WC; Santos SR
    Ther Drug Monit; 1997 Dec; 19(6):705-10. PubMed ID: 9421115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG; Bayon JE; González-Gallego J
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sex and age on caffeine pharmacokinetics in cattle.
    Janus K; Antoszek J
    Res Vet Sci; 2000 Aug; 69(1):33-7. PubMed ID: 10924391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of dietary restriction on the metabolism of theophylline and antipyrine in the ageing female BN/BiRij rat.
    Groen K; Breimer DD; Brouwer A; Schijff G; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):143-7. PubMed ID: 7616391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
    Van Geel CA; Van Bezooijen CF
    Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.